Note: Ingredients listed on restricted chemical lists
EC/CAS
26523-78-4
Name of the chemical
Tris(nonylphenyl) phosphite (TNPP)
Concentration
N/A
EC/CAS
84852-15-3
Name of the chemical
Nonylphenol (NP), mixed isomers
Concentration
N/A
EC/CAS
247-759-6
Name of the chemical
tris(nonylphenyl) phosphite
Concentration
N/A
EC/CAS
284-325-5
Name of the chemical
4-Nonylphenol/verzweigte Seitenkette
Concentration
N/A
General Information
Revision date
2021-03-01
Product name
PARALOID EXL-3361 Engineering Resin
1.2.1 Relevant identified uses
Plastics Additive
Emergency telephone
0031 115 694 982
Icons in SDS
Company Information
company name
DOW CHEMICAL COMPANY LIMITED
e-mail address of the competent person responsible for the Safety Data Sheet
SDSQuestion@dow.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H411
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
CLP CLASSIFICATION
Skin sensitisation - Category 1 - H317 Long-term (chronic) aquatic hazard - Category 2 - H411 For the full text of the H-Statements mentioned in this Section, see Section 16. ® ™ Trademark of The Dow Chemical Company ("Dow") or an affiliated
2.2 Label elements
Labelling according to Regulation (EC) No 1272/2008:
Hazard statements
H317 May cause an allergic skin reaction. H411 Toxic to aquatic life with long lasting effects.
Precautionary statements
P261 Avoid breathing dust, fume, gas, mist, vapours and/or spray. P273 Avoid release to the environment. P280 Wear protective gloves. P333 + P313 If skin irritation or rash occurs: Get medical advice/ attention. P362 + P364 Take off contaminated clothing and wash it before reuse. P391 Collect spillage.
2.3 Other hazards
This product contains no substances assessed to be PBT or vPvB at levels of 0.1% or higher. Endocrine disrupting properties
Environmental hazards
Nonylphenol - The substance is considered to have endocrine disrupting properties according to REACH Article 57(f) for the environment. Human Health: The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
